
Tumors that arise from specialized hormone-producing cells scattered along the digestive tract, varied, often slow-growing, and sometimes silent for years.
GutLiv funds research into non-invasive grading markers and functional-imaging techniques that distinguish indolent NETs from aggressive ones, so that slow-growing tumors can be watched safely while aggressive ones are treated early.